Lubbock TX 溃疡性结肠炎临床试验
9项针对 溃疡性结肠炎的研究正在 Lubbock及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
招募中2 期
- Site US-015, Lubbock
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
招募中2 期
- GI Alliance - Lubbock /ID# 283920, Lubbock
- Caprock Gastro Research - Lubbock /ID# 283921, Lubbock
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
招募中1/2 期欢迎健康志愿者
- Xencor Investigative Site, Lubbock
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
招募中2 期
- GI Alliance - Lubbock, Lubbock
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
招募中3 期
- GI Alliance - Lubbock - Site Number: 8400092, Lubbock
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
招募中4 期
- West Texas Research Institute, Lubbock
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
招募中3 期
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
招募中3 期
- Texas Digestive Disease Consultants dba GI Alliance - Lubbock - Site Number: 8400092, Lubbock
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
招募中2 期
- Mirador Therapeutics Selected Site, Lubbock
其他城市的 溃疡性结肠炎试验
- New York City, NY24 项研究
- Orlando, FL23 项研究
- Miami, FL22 项研究
- Houston, TX18 项研究
- San Antonio, TX16 项研究
- San Diego, CA16 项研究
- Tacoma, WA15 项研究
- Chicago, IL15 项研究
- Tyler, TX14 项研究
- St. Louis, MO14 项研究
- Colorado Springs, CO14 项研究
- Los Angeles, CA13 项研究
Lubbock的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年9月30日。每项研究自行设定入选标准，由研究团队决定谁能参与。